In earlier communications (1, 2) there was described a rapid method for diagnosing meningococcal meningitis and ascertaining the serological type of the organism by means of precipitin tests carried out on the cerebrospinal fluid with monovalent antisera. It was pointed out that a certain number of negative results occurred when the spinal fluid tested was drawn after the commencement of intrathecal serum therapy, and, furthermore, that in some instances negative results were due apparently to the fact that the test was not sufficiently sensitive to demonstrate the very small amounts of specific precipitinogen which might be present in some fluids. At that time only rabbit monovalent antimeningococcus sera were available. It was thought that the percentage of negative results on fluids drawn before commencement of therapy might be reduced when sera of higher precipitin titer became available.Since the publication of these papers there has become available both Type I and Type II monovalent antimeningococcus serum, prepared in horses, which has a precipitin titer considerably higher than our best monovalent rabbit serum. These sera have been used in the tests carried out on spinal fluids since that date. Moreover, the technique of the precipitin test has also been modified so as to give more delicate readings.
Material and TechniqueSpinal fluid was obtained from cases of known meningococcal meningitis and from other cases of meningitic infection. The precipitin test was carried out with 317 on